Safety and Efficacy of SJP-0035 Ophthalmic Solution in Patients With Moderate to Severe Corneal Epithelial Disorders
Status:
Completed
Trial end date:
2017-05-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether SJP-0035 ophthalmic solution is effective
in promoting corneal epithelial wound healing in conditions associated with corneal
epithelial disorders.